Picture of Respiri logo

RSH Respiri Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m-15.79%
3m-16.02%
6m-15.72%
1yr-38.46%
Volume Change (%)
10d/3m-28.35%
Price vs... (%)
52w High-41.86%
50d MA-18.14%
200d MA-16.78%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-173.27%
Return on Equity-223.57%
Operating Margin-793.79%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202430th Jun 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Respiri EPS forecast chart

Profile Summary

Respiri Limited is an Australia-based e-health software-as-a-service (SaaS) company that supports respiratory health management and remote patient monitoring (RPM). It is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. The Wheezo is also used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children (two years and older).

Directors

Last Annual
June 30th, 2023
Last Interim
December 31st, 2023
Incorporated
May 7th, 1987
Public Since
July 14th, 2000
No. of Employees
2
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
1,059,868,924

RSH Share Price Performance

Upcoming Events for RSH

Full Year 2024 Respiri Ltd Earnings Release

Similar to RSH

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Medical Technologies logo

Allegra Medical Technologies

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

Picture of Anteris Technologies logo

Anteris Technologies

au flag iconAustralian Stock Exchange - SEATS

FAQ